DHX 11.25 Dice Holdings $DHX Hit a 52 week high of 11.30

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
DHX 11.25 Dice Holdings $DHX Hit a 52 week high of 11.30 Closing the day 09:45 at 11.25 -0.06 -0.53% With a day low of 11.24 and a total volume of 18,437.

DHX Recent Posts: http://investorshangout.com/Dice-Holdings-Inc-DHX-50737/

DHX Dice Holdings Recent Headline News

Dice Holdings, Inc. to Present at Upcoming Investor Events
PR Newswire - 2 hrs 30 mins ago
Dice Holdings, Inc. (NYSE: DHX) today announced that the Company will be participating in upcoming investor events.
DHX: 11.24 (-0.07)

King Digital Entertainment (KING) Jumps: Stock Rises 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 37 mins ago
King Digital Entertainment plc (KING) was a big mover last session, as the company saw its shares rise over 7% on the day.
DHX: 11.24 (-0.07), DTSI: 33.13 (+0.32), LOGM: 51.86 (+0.05), KING: 15.89 (+0.84)

Can The Uptrend Continue for DICE HOLDINGS (DHX)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 7:16AM CST
Can The Uptrend Continue for DICE HOLDINGS (DHX)?
DHX: 11.24 (-0.07)

Jiayuan.com International Ltd. (DATE) Jumps: Stock Up 8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 13, 8:32AM CST
Jiayuan.com International Ltd. (DATE) was a big mover last session, as the company saw its shares rise more than 8% on the day.
DHX: 11.24 (-0.07), DATE: 5.34 (+0.07), GAME: 6.54 (+0.02), XOXO: 14.29 (-0.02)

49.4% Return Seen to Date on SmarTrend Dice Holdings Call (DHX)
Comtex SmarTrend(R) - Wed Nov 12, 4:50PM CST
SmarTrend identified an Uptrend for Dice Holdings (NYSE HX) on February 27th, 2014 at $7.49. In approximately 9 months, Dice Holdings has returned 49.40% as of today's recent price of $11.19.
DHX: 11.24 (-0.07)

Global Eagle Entertainment (ENT) in Focus: Stock Up 5.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:37AM CST
Global Eagle Entertainment Inc. (ENT) was a big mover last session, as the company saw its shares rise more than 5% on the day.
DHX: 11.24 (-0.07), XOXO: 14.29 (-0.02), LOV: 3.76 (+0.01), ENT: 13.05 (-0.03)

XO Group Inc. (XOXO) in Focus: Stock Jumps 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:18AM CST
XO Group Inc. (XOXO) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
DHX: 11.24 (-0.07), RATE: 12.20 (+0.16), GAME: 6.54 (+0.02), XOXO: 14.29 (-0.02)

Dice Holdings Has Returned 38.7% Since SmarTrend Recommendation (DHX)
Comtex SmarTrend(R) - Wed Nov 05, 10:59AM CST
SmarTrend identified an Uptrend for Dice Holdings (NYSE HX) on February 27th, 2014 at $7.49. In approximately 8 months, Dice Holdings has returned 38.72% as of today's recent price of $10.39.
DHX: 11.24 (-0.07)

NYSE stocks posting largest percentage increases
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
DHX: 11.24 (-0.07), HLF: 37.44 (-0.41), CBM: 23.28 (-0.08), ESI: 10.10 (+0.08), JMP: 7.50 (-0.05), THR: 25.45 (+0.26), AU: 8.81 (+0.09), VSLR: 12.00 (+0.30), NLS: 14.60 (+0.32), CCG: 7.25 (unch), DAC: 5.83 (-0.07), CVD: 100.44 (-0.09)

Dice Holdings (DHX) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Tue Nov 04, 10:12AM CST
Trade-Ideas LLC identified Dice Holdings (DHX) as a strong and under the radar candidate
DHX: 11.24 (-0.07)

Brightcove, Inc. (BCOV) Surges: Stock Rises 18.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:11AM CST
Brightcove, Inc. (BCOV) was a big mover last session, as the company saw its shares rise nearly 19% on the day.
DHX: 11.24 (-0.07), BCOV: 7.10 (unch), GAME: 6.54 (+0.02), LOV: 3.76 (+0.01)

Dice Holdings' (DHX) CEO Michael Durney on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 4:50PM CDT

DHX: 11.24 (-0.07)

Dice Holdings tops Street 3Q forecasts
Automated Insights - Thu Oct 30, 8:51AM CDT
NEW YORK (AP) _ Dice Holdings Inc. (DHX) on Thursday reported profit of $9.5 million in its third quarter.
DHX: 11.24 (-0.07)

Dice Holdings beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:05AM CDT

DHX: 11.24 (-0.07)

Dice Holdings, Inc. Reports Third Quarter 2014 Results
PR Newswire - Thu Oct 30, 6:00AM CDT
-- Revenues increased 29% year-over-year to $67.6 million in the third quarter
DHX: 11.24 (-0.07)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 4:30PM CDT

FIS: 59.25 (-0.05), HST: 22.66 (-0.07), CRR: 47.62 (-0.46), CAH: 80.73 (+0.07), AMT: 99.78 (-0.17), ACIW: 19.27 (+0.39), GTI: 4.18 (-0.02), IDA: 61.39 (+0.21), CRCM: 8.81 (-0.16), CVRR: 23.04 (-0.08), BGCP: 8.56 (-0.02), GOV: 23.09 (+0.01), DFT: 31.29 (-0.24), APO: 22.64 (+0.01), FIG: 7.62 (+0.01), AMAG: 34.48 (+0.24), HAR: 105.01 (-1.56), AVP: 9.98 (-0.28), EXLS: 28.85 (+0.20), INGR: 80.53 (+0.69), ALU: 3.08 (+0.03), INCY: 69.14 (-2.07), COP: 70.65 (+0.30), GEL: 46.93 (-0.07), COR: 38.42 (+0.01), GTLS: 43.13 (-0.87), BWA: 54.90 (-0.40), CARB: 11.64 (+0.16), GLOP: 23.33 (-0.33), IDCC: 50.76 (+1.09), HEES: 37.02 (-0.16), BCO: 21.49 (+0.24), DST: 100.25 (+0.90), EPD: 37.38 (+0.11), ABMD: 33.10 (-0.38), CEVA: 16.93 (+1.05), BLL: 64.67 (-0.49), GBX: 62.80 (-0.70), GNC: 43.55 (-0.11), CVI: 47.45 (+0.35), ACOR: 33.46 (-0.27), I: 17.80 (-0.03), FCN: 41.10 (+0.01), CRNT: 1.12 (-0.03), DHX: 11.24 (-0.07), BG: 88.73 (-0.02), CME: 85.20 (+0.06), FCH: 10.58 (-0.04), ALLE: 52.28 (+0.16), AUDC: 4.56 (-0.06), APD: 135.30 (-0.23), DBD: 35.33 (+0.15), HGG: 6.07 (-0.09), CBM: 23.28 (-0.08), CNSL: 27.08 (-0.02), ATK: 111.06 (-0.08), ANR: 2.39 (-0.03), CI: 102.44 (-0.27), ABC: 88.97 (-0.11), GG: 19.62 (+0.37)

16.0% Return Seen to Date on SmarTrend Dice Holdings Call (DHX)
Comtex SmarTrend(R) - Wed Oct 29, 9:52AM CDT
SmarTrend identified an Uptrend for Dice Holdings (NYSE HX) on February 27th, 2014 at $7.49. In approximately 8 months, Dice Holdings has returned 16.02% as of today's recent price of $8.69.
DHX: 11.24 (-0.07)

Dice Holdings Inc (DHX) Stock Research Links

DHX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Enanta Pharmaceuticals Highlights Fiscal Q1 2025 Performance

Updated Category News Views 188

Enanta Pharmaceuticals Reports Financial Highlights for Q1 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology firm, has revealed its financial results for the first fiscal quarter ending December 31, 2024. This quarter is seen as a crucial period for the company as it expands its innovative drug portfolio targeting viral and immunological...

Continue Reading
Friedman Industries Reports Impressive First Quarter Growth

Updated Category News Views 98

Friedman Industries Reports Significant First Quarter Growth Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an...

Continue Reading
From Doubt to Delicious: The Rise of Raising Cane's

Updated Category News Views 308

Overcoming Doubt: The Birth of Raising Cane's The journey of Raising Cane's is not just about chicken fingers; it's a story of perseverance. Founded by Todd Graves, the chain has become a testament to how challenges can fuel passion and success. Graves faced significant skepticism from those who thought the concept was flawed due to its limited menu. Motivation Behind...

Continue Reading
Understanding Japan's Impact on US Tech Stock Dynamics

Updated Category News Views 371

The Influence of Japan's Real Rates on US Markets The current landscape of the S&P 500 bull market has been subject to various influences, and surprisingly, one of the most significant factors is not a domestic recession in the US but rather Japan's extraordinarily negative real interest rates compared to those in the US. This insightful perspective comes from BCA...

Continue Reading
Ocean Ledger Secures Funding to Enhance Coastal Risk Solutions

Updated Category News Views 171

Ocean Ledger Secures Funding for Coastal Risk Management Ocean Ledger, a promising geospatial analytics startup, has recently completed a successful funding round, securing $900K to enhance its capabilities in coastal risk management. This investment is poised to support the development of innovative solutions aimed at forecasting coastal risks, benefitting various...

Continue Reading